Learn about the global psoriatic arthritis treatment market through The Business Research Company, which provides information on psoriatic arthritis treatment market size, psoriatic arthritis treatment market drivers and restraints, psoriatic arthritis treatment market players, the COVID-19 impact on the psoriatic arthritis treatment market, and more.

The global psoriatic arthritis treatment market size is expected to grow from $7.89 billion in 2021 to $8.92 billion in 2022 at a compound annual growth rate (CAGR) of 13.1%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The psoriatic arthritis treatment market is expected to reach $13.17 billion in 2026 at a CAGR of 10.2%.

The rise in the prevalence of psoriasis & psoriatic arthritis disease boosted the growth of the psoriatic arthritis treatment market.

Request A Sample For The Global Psoriatic Arthritis Treatment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2866&type=smp

The psoriatic arthritis treatment market consists of the sale of psoriatic arthritis drugs used for the treatment of psoriatic arthritis by entities producing drugs for psoriatic arthritis. Psoriasis arthritis is a chronic inflammatory joint disease that is associated with psoriasis, whose symptoms vary from person to person.

Global psoriatic arthritis treatment market segments include:

By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Biologics, Others

By Route of Administration: Oral, Parenteral, Topical

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

The development of novel drugs such as Janus kinase (JAK) inhibitors for treating psoriatic arthritis is shaping the market. Janus kinase (JAK) inhibitors are orally administered small molecules emerging as a novel treatment for psoriatic arthritis patients. There are three JAK inhibitors approved for the treatment of autoimmune diseases – tofacitinib, baricitinib, and upadacitinib. Among them, Xeljanz (tofacitinib) and Xeljanz (tofacitinib) XR are the first Janus kinase inhibitors that have been approved by the Food and Drug Administration (FDA) and the European Medicines Agency (EMA). They are used to treat adult patients with active psoriatic arthritis (PsA), who have had an inadequate response or intolerance to methotrexate or other disease-modifying antirheumatic drugs (DMARDs).

TBRC’s psoriatic arthritis treatment market report covers:

Major Market Players: AbbVie, Amgen, Johnson & Johnson, Bristol-Myers Squibb Company, Celgene Corporation, Novartis, Eli Lilly And Company, Pfizer, UCB Biosciences Inc and Hoffmann La Roche Ltd.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)

The Psoriatic Arthritis Treatment Global Market Report 2022–Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides psoriatic arthritis treatment market overviews, analyzes and forecasts market size, share, psoriatic arthritis treatment market players, psoriatic arthritis treatment market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s psoriatic arthritis treatment market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here is a list of similar reports from The Business Research Company:

Orthopedic Braces And Support Devices And Equipment Global Market Report 2022

Orthopedic Devices Global Market Report 2022

Arthroscopy Devices And Equipment Global Market Report 2022

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model